PTPA and hepatitis C virus infection: Suppression and impairment of anti-viral activity of interferon α (IFNα) has been shown in hepatitis C infection through inhibition of Jak1/Tyk2/STAT1 phosphorylation [30] and upregulation of PP2A dependent upon NS5A protein [24].